Birchtech Corp.

https://www.birchtech.com/

Birchtech Corp. is an environmental technology company dedicated to advancing solutions for air and water purification. Headquartered in Corsicana, Texas, with additional operational and R&D facilities, the company's mission is to provide effective, affordable, and sustainable technologies for utilities and critical infrastructure, ensuring cleaner air and water.

The company specializes in activated carbon technologies, with its core business centered on patented Sorbent Enhancement Additive (SEA®) technologies for mercury emissions capture in the coal-fired utility sector. Birchtech is also expanding significantly into water purification, developing disruptive solutions for contaminant removal, particularly per- and polyfluoroalkyl substances (PFAS and PFOS), through smart carbon management, turnkey water treatment services, and advanced testing capabilities via its Design Centers.

Led by President and CEO Richard MacPherson, who founded the company in 2008, Birchtech Corp. recently uplisted its common stock to the NYSE American (trading began February 26, 2026) and completed a $15 million capital raise to fuel the expansion of its water treatment business. The company also secured a $78 million federal court judgment in a patent infringement case in December 2025, underscoring the strength of its intellectual property. Birchtech is actively commercializing its water treatment solutions, securing initial purchase orders and pursuing strategic partnerships to scale its operations and market positioning.

Latest updates

Birchtech Targets Water Treatment Market with Conference Blitz

  • Birchtech will exhibit at four water industry conferences in May and June 2026.
  • Dr. Nicholas Lentz will present on PFAS removal techniques at the PA AWWA and ASMS conferences.
  • The company will showcase its Design Center Analytical Services, SEA-IX resin, and granular activated carbon (GAC) solutions.
  • Birchtech aims to engage with utilities, engineering firms, and research institutions across North America.

Birchtech's aggressive conference schedule signals a concerted effort to expand its presence in the rapidly growing water treatment market, particularly concerning PFAS remediation. The company's focus on a media-agnostic approach, while potentially advantageous, also introduces complexity in scaling operations and managing diverse customer needs. The timing aligns with increasing regulatory pressure and public concern around water contamination, creating both opportunity and risk for Birchtech.

Regulatory Headwinds
Increased scrutiny of PFAS remediation technologies and stricter regulatory requirements could impact Birchtech's growth trajectory and necessitate ongoing adaptation of its solutions.
Execution Risk
The success of Birchtech's strategy hinges on effectively engaging with a diverse range of utilities, from large metropolitan systems to smaller rural operations, requiring tailored solutions and potentially complex sales cycles.
Competitive Landscape
The water treatment market is increasingly competitive, and Birchtech's media-agnostic approach will need to demonstrate a clear advantage over specialized competitors offering single-technology solutions.

Birchtech Secures $78 Million Judgment, Upslists to NYSE American

  • Birchtech secured a final judgment of approximately $78 million in a patent infringement case, up from an initial $57 million verdict.
  • The company successfully uplisted to the NYSE American and raised gross proceeds of approximately $16.6 million through a public offering.
  • Fourth-quarter product revenues increased by 19.8% year-over-year to $3.6 million, partially offset by a one-time licensing payment in the prior year.
  • Birchtech announced initial purchase orders of approximately $0.9 million for water treatment services from a mid-Atlantic power utility.

Birchtech’s recent developments highlight the growing demand for specialty activated carbon technologies in both air and water purification, driven by stricter environmental regulations and increasing concerns about contaminants like PFAS. The successful patent litigation and capital raise provide a strong foundation for expansion, but the company’s ability to execute on its commercial strategy and manage legal risks will be key to unlocking long-term value. The uplisting to the NYSE American signals a shift towards greater institutional investor visibility and scrutiny.

Legal Risk
The outcome of the appeal filed by the defendants in the patent infringement case will significantly impact Birchtech’s ability to collect the $78 million judgment and its future financial performance.
Commercial Traction
The ability of Birchtech to expand its water treatment solutions business beyond the initial $0.9 million purchase order and secure additional licensed utilities will be critical to achieving long-term growth.
Capital Allocation
How Birchtech utilizes the $16.6 million raised through the public offering – particularly regarding the planned Carbon Rejuvenation™ facility – will determine the success of its strategic expansion.

Birchtech Enters Ion Exchange Resin Market with $255M Opportunity

  • Birchtech launched a new line of nuclear-grade ion exchange resins, SEA-IX™, targeting a $185–$255 million addressable market.
  • The company has already secured $1 million in purchase orders, including a $0.4 million order in March 2026, with initial supply to a coal-fired power plant underway.
  • Birchtech claims SEA-IX resins offer improved process throughput and reduced material usage compared to competitors.
  • The product line complements Birchtech’s existing water treatment platform, which includes analytical services, rejuvenation services, and turnkey solutions.

Birchtech’s move into the ion exchange resin market represents a strategic expansion beyond its core activated carbon business, capitalizing on growing demand for high-purity water treatment solutions driven by the expansion of nuclear power and increasing regulatory pressure on industrial wastewater. The $185–$255 million addressable market suggests a significant growth opportunity, but also highlights the competitive intensity of the sector, where established players control a large portion of the market. Birchtech’s U.S.-based distribution hub offers a potential advantage in terms of lead times and supply chain resilience.

Market Penetration
The success of SEA-IX hinges on Birchtech’s ability to displace the two dominant global suppliers, currently holding 70% market share, and secure contracts with major nuclear operators.
Competitive Response
Existing ion exchange resin suppliers will likely respond to Birchtech’s entry with price adjustments or product innovations, potentially compressing margins.
Regulatory Scrutiny
Increased demand for nuclear power and stringent water quality regulations could accelerate adoption of SEA-IX, but also expose Birchtech to heightened regulatory oversight and compliance costs.

Birchtech to Pitch Investment Thesis at iAccess Alpha Conference

  • Birchtech Corp. CEO Richard MacPherson will present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026.
  • The presentation will be webcasted at 12:30 p.m. Eastern time and include one-on-one investor meetings.
  • Birchtech specializes in activated carbon technologies for air and water treatment, including mercury emissions capture and PFAS/PFOS removal.
  • MZ Group is handling investor relations and scheduling meetings for Birchtech.

Birchtech's participation in this conference signals an effort to actively engage with institutional investors and highlight its position in the growing environmental technology sector. The company's focus on activated carbon, particularly for mercury capture and emerging contaminants like PFAS, aligns with increasing regulatory pressure and corporate sustainability initiatives. Success will depend on demonstrating a clear path to profitability and scalability within these niche markets.

Investor Sentiment
The conference provides a key opportunity to gauge investor appetite for Birchtech's growth strategy, particularly given the company's focus on specialized, capital-intensive technologies.
PFAS Focus
How Birchtech articulates the commercial viability of its PFAS/PFOS water purification technologies will be critical, as regulatory scrutiny and remediation costs surrounding these chemicals are intensifying.
Execution Risk
The company's ability to secure and execute on new contracts, especially in the competitive water purification market, will determine if it can sustain its current valuation.

Birchtech Secures $78 Million Patent Judgment, Upslists to NYSE American

  • Birchtech won a final federal court judgment of approximately $78 million in a patent infringement case against operating companies of refined coal, initiating collection proceedings.
  • The company completed a reverse stock split and began trading on the NYSE American, concurrent with a $15 million capital raise.
  • Birchtech has received approximately $37 million in license fees and settlements since 2020 related to its patented SEA® mercury capture technology.
  • The company is planning to begin construction of its first granular activated carbon (GAC) rejuvenation facility in 2026, with operations expected to begin in late 2027.

Birchtech's strategic shift towards water treatment solutions and its focus on recurring revenue models reflect a broader industry trend towards integrated environmental services and lifecycle management. The company’s recent capital markets actions and listing on the NYSE American suggest an effort to attract institutional investors and increase liquidity, but the success of its long-term strategy will depend on execution and navigating potential regulatory and litigation headwinds.

Litigation Risk
The appeal filed by defendants in the patent infringement case poses a risk to the full realization of the $78 million judgment, which could significantly impact Birchtech’s financial outlook.
Water Adoption
The success of Birchtech’s full-service water treatment model hinges on converting pilot programs and municipal partnerships into multi-year carbon supply contracts, a process that may be slower than anticipated.
Rejuvenation Scale
The viability of the Carbon Rejuvenation™ program depends on the facility’s ability to process sufficient volume of spent carbon to achieve economies of scale and generate a recurring revenue stream.

Birchtech Secures $15 Million Capital Infusion, Moves Listing to NYSE American

  • Birchtech Corp. priced a public offering of 6.25 million shares at $2.40 per share, raising approximately $15 million in gross proceeds.
  • The company is uplisting from the OTCQB market tier to the NYSE American stock exchange, commencing trading on February 26, 2026.
  • Proceeds will be used for operating expenses, working capital, and general corporate purposes.
  • Underwriters have a 30-day option to purchase an additional 937,500 shares to cover over-allotments.

Birchtech's capital raise and exchange listing reflect growing investor interest in sustainable technologies, particularly those addressing water and air purification challenges. The move to NYSE American signals a desire for greater institutional investor participation and liquidity. The company's focus on activated carbon technologies, especially for emerging contaminants like PFAS, positions it within a rapidly expanding market driven by stricter environmental regulations and increasing public awareness.

Capital Allocation
The company's ability to effectively deploy the new capital will be critical; investors should monitor if the funds translate into accelerated growth or improved profitability.
Market Acceptance
The NYSE American listing may increase visibility and liquidity, but the stock's performance will ultimately depend on investor confidence in Birchtech's technology and market position.
Regulatory Landscape
Increased scrutiny of PFAS and other forever chemicals could create both opportunities and challenges for Birchtech, impacting demand for its water purification technologies.

Birchtech to Uplist to NYSE American, Launches Concurrent Offering

  • Birchtech Corp. (TSX: BCHT) anticipates listing on the NYSE American exchange, replacing its current OTCQB listing.
  • Trading on NYSE American is expected to commence on or around February 12, 2026, pending final approvals.
  • The company is simultaneously launching a concurrent offering of common stock, contingent on the NYSE American listing approval.
  • Birchtech will remain listed on the Toronto Stock Exchange (TSX).

Birchtech’s move to the NYSE American signals a desire to access a broader investor base and potentially command a higher valuation. This uplisting is a common step for companies seeking to mature and attract institutional capital, particularly those in specialized sectors like environmental technologies. The concurrent offering suggests a need for additional capital to fund growth initiatives, likely tied to expanding its water purification platform and securing further utility licenses.

Investor Sentiment
The success of the concurrent offering will be a key indicator of investor appetite for Birchtech’s stock following the exchange upgrade, potentially impacting future capital raising efforts.
Trading Volume
Increased visibility and liquidity on the NYSE American may initially boost trading volume, but sustained activity will depend on attracting institutional investors and broadening retail awareness.
Regulatory Scrutiny
The concurrent offering will be subject to SEC review, and any delays or modifications could impact the timing and size of the offering, potentially affecting the company’s short-term financial goals.

Birchtech Moves to Enforce $78 Million Judgment Against CERT

  • Birchtech is formally pursuing enforcement of a $78 million judgment won against CERT entities following a 2024 jury trial.
  • The judgment, related to patent infringement, became enforceable on February 2, 2026, after a 30-day stay expired.
  • CERT has filed a notice of appeal and may seek a bonded stay to prevent enforcement while the appeal is pending.
  • Birchtech intends to use various enforcement methods, including asset discovery, liens, and garnishments, to collect the full judgment amount.
  • Interest continues to accrue on the $78 million judgment during the appeal period.

This judgment represents a significant win for Birchtech, potentially bolstering its financial position and validating its intellectual property. However, the ongoing appeal introduces substantial uncertainty and risk, as a reversal could negate the recovery. The case highlights the increasing importance of IP protection in the specialty materials sector, where innovation and patent enforcement are key competitive differentiators.

Appeal Outcome
The success of CERT’s appeal will directly determine Birchtech’s ability to collect the full judgment amount, and the timeline for recovery remains highly uncertain.
Bonded Stay
Whether CERT secures a bonded stay will dictate whether Birchtech can immediately pursue asset seizure and other enforcement actions, impacting the speed of recovery.
Asset Discovery
The thoroughness of Birchtech’s asset discovery process will be critical in determining the collectability of the judgment, as CERT’s financial resources and solvency remain unknown.

Birchtech Validates Carbon Rejuvenation, Targeting PFAS Compliance Costs

  • Birchtech demonstrated its Carbon Rejuvenation process, thermally reactivating spent granular activated carbon (GAC) for PFAS removal.
  • Demonstrations with municipal water utilities showed rejuvenated GAC performing comparably to virgin carbon.
  • The process aims to reduce reliance on virgin carbon, lower lifecycle costs, and minimize disposal requirements.
  • Birchtech emphasizes a regional deployment model for carbon rejuvenation, aligning with utility priorities.

The escalating costs and regulatory scrutiny surrounding PFAS remediation are driving demand for innovative and sustainable solutions. Birchtech’s Carbon Rejuvenation initiative directly addresses this need by offering a potentially lower-cost alternative to virgin activated carbon, while also mitigating environmental concerns related to landfill disposal. The regional deployment strategy positions Birchtech to capitalize on utilities’ increasing focus on localized supply chains and infrastructure resilience.

Commercialization
The speed at which Birchtech can scale its Carbon Rejuvenation service beyond demonstration projects will be critical to realizing the claimed cost savings and market differentiation.
Regulatory Landscape
Increased regulatory pressure on PFAS remediation and landfill disposal could accelerate adoption of Birchtech’s solution, but also create uncertainty around future compliance standards.
Utility Adoption
Whether municipal water utilities will prioritize regional carbon rejuvenation over established virgin carbon supply chains, despite the potential benefits, remains to be seen.

Birchtech Initiates 1-for-5 Reverse Split to Facilitate Uplisting

  • Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) approved a 1-for-5 reverse stock split, effective December 26, 2025.
  • The split aims to increase the share price to support a planned uplisting and improve marketability.
  • The trading symbol will remain unchanged, with a temporary “D” appended to the OTCQB ticker for 20 business days.
  • Shareholders holding shares in book-entry form or brokerage accounts are not required to take action.

The reverse stock split signals Birchtech's ambition to access a broader pool of institutional capital, a common tactic for companies seeking to enhance their market profile and potentially fund future growth initiatives. While the split itself doesn't fundamentally alter the company's value, it's a strategic maneuver intended to make the stock more attractive to larger investors, particularly those with mandates restricting investments in low-priced shares. This move suggests Birchtech is actively pursuing expansion and may be considering significant capital market transactions in the near future.

Uplisting Prospects
The success of this reverse split hinges on Birchtech’s ability to secure a listing on a higher-tier exchange, which will require meeting specific financial and operational criteria.
Institutional Adoption
How effectively Birchtech can attract institutional investors following the split will be a key indicator of the strategy’s long-term viability and impact on liquidity.
Fractional Share Handling
The rounding-up policy for fractional shares could create a slight dilution effect, and the company's transparency regarding this process will be important for investor confidence.

Birchtech Secures $78 Million Patent Infringement Judgment

  • Birchtech received a final judgment of approximately $78 million from the U.S. District Court of Delaware following a 2024 patent infringement jury verdict against several energy companies.
  • The judgment includes pre- and post-judgment interest, with additional interest accruing daily until payment.
  • Birchtech has secured nine license and/or supply agreements and received $37 million in license fees and settlements related to its patented technologies.
  • The company intends to use the funds to accelerate development of novel water purification technologies targeting PFAS contaminants.

Birchtech’s victory represents a significant win for patent holders challenging industry incumbents, particularly in sectors facing increasing environmental scrutiny. The $78 million judgment provides a substantial war chest for the company to pursue its expansion into water purification, a market estimated to be worth billions as regulations surrounding PFAS contamination tighten. This case highlights the growing importance of intellectual property protection in specialized technology niches and the potential for litigation to reshape industry dynamics.

Litigation Risk
The remaining defendants in the Iowa lawsuit could challenge the judgment or seek further delays, potentially impacting the timing and amount of Birchtech’s recovery.
Technology Adoption
The pace at which utilities adopt Birchtech’s water purification technologies will determine the success of its expansion into that market and the realization of projected revenue growth.
Financial Discipline
How Birchtech manages the influx of capital from the judgment will be critical; aggressive investment in new technologies carries execution risk and could dilute existing shareholder value.

Birchtech to Pitch Investment Strategy at iAccess Alpha Conference

  • Birchtech Corp. has been invited to present at the iAccess Alpha Virtual Best Ideas Winter Conference on December 9-10, 2025.
  • CEO Richard MacPherson will host one-on-one investor meetings and a virtual presentation at 11:00 a.m. Eastern time on December 9, 2025.
  • The presentation will be webcast via Webcaster5 (link provided).
  • MZ Group is handling investor relations for the event.

Birchtech’s participation in this conference signals an effort to actively engage with institutional investors and highlight its position in the growing environmental technology sector. The company’s focus on activated carbon for both air and water purification, including emerging contaminants like PFAS, positions it within a market driven by increasingly stringent environmental regulations and a demand for sustainable solutions. The conference provides a platform to communicate this value proposition and potentially attract further investment.

Investor Sentiment
The conference provides a key opportunity to gauge investor appetite for Birchtech’s strategy, particularly given the company’s focus on specialized environmental technologies.
PFAS Development
How Birchtech articulates progress on its disruptive water purification technologies, specifically addressing PFAS, will be a critical indicator of future revenue potential.
Clean Coal Transition
The continued reliance on mercury emissions capture technology for the coal-fired utility sector, and the potential impact of accelerating decarbonization efforts, warrants close observation.
CID: 538